You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

No matches

Gastroenterology

UEGW 2024 | Something to Chew On: Exploring Biologics in EoE Management

Prof. Salvatore Oliva and Dr. Milli Gupta discuss the importance of long-term care and multidimensional assessment.

MD, PhD

Salvatore Oliva +1 more

25 minutes

Learning objectives

Recognize the chronic, progressive nature of type 2 inflammation in EoE and why long-term management is important
Describe what assessments can be used to monitor treatment response and when to follow up with patients in your clinical practice

Description

In this ADVENT symposium at UEG Week 2024, Prof. Salvatore Oliva and Dr. Milli Gupta discuss the importance of long-term management of EoE due to the chronic, progressive nature of the pathophysiology of type 2 inflammation. Regular monitoring of histology and endoscopy, not just symptoms, is key for assessing treatment response.

About these experts

Gastroenterology

MD, PhD

Salvatore Oliva

Professor of Medicine | Associate Professor of Pediatrics in the Maternal and Child Health Department | Sapienza University of Rome; Consultant Pediatric Gastroenterologist | Umberto I University Hospital, Rome, Italy

Gastroenterology

MD, FRCPC

Milli Gupta

Associate Clinical Professor of Medicine | Division of Gastroenterology and Hepatology | Department of Medicine University of Calgary, Calgary, Alberta, Canada

Related resources

Gastroenterology

4 min

expert video

Overview of EoE Pathophysiology and the Impact on Patient Burden

ADVENT On Air | Dysphagia in EoE: How Can You See Beyond Patients’ Adaptive Behaviors?

Gastroenterology

17 min

Podcast

ADVENT On Air | Dysphagia in EoE: How Can You See Beyond Patients’ Adaptive Behaviors?

ADVENT On Air | More Than Just Difficulty Swallowing: EoE Burden and Diagnosis

Gastroenterology

12 min

Podcast

Keeping an Eye on Pediatric EoE

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region

UEGW 2024 | Something to Chew On: Exploring Biologics in EoE Management

Learning objectives

Description

About these experts

Salvatore Oliva

Milli Gupta

Related resources

Overview of EoE Pathophysiology and the Impact on Patient Burden

ADVENT On Air | Dysphagia in EoE: How Can You See Beyond Patients’ Adaptive Behaviors?

ADVENT On Air | More Than Just Difficulty Swallowing: EoE Burden and Diagnosis

Adaptive Behaviors in EoE Infographic

Pediatric EoE Disease Burden Infographic

EoE Burden and Pathophysiology of Type 2 Inflammation

Piecing Together the Puzzle in Patients With EoE

Assessing EoE: Assessing Symptoms in Patients With EoE

2021: EoE Year in Review

2021: EoE Year in Review - Pathophysiology

2022: EoE Year in Review

Assessing EoE: Assessing Histologic Features in EoE

Assessing EoE: Measuring Quality of Life in Patients With EoE

Assessing EoE: Using Endoscopic Features to Assess Disease Status

Complex EoE Pathophysiology Beyond Esophageal Eosinophilia

Cumulative Exposure to Corticosteroids in Type 2 Inflammatory Diseases

EoE: A Chronic, Progressive, Type 2 Inflammatory Disease Infographic

Eosinophilic Esophagitis (EoE) Interactive Patient Case

Esophageal Dilation Does Not Impact Underlying Inflammation in EoE

Food Bolus Impaction: An Opportunity to Diagnose EoE

Gap in Care Leads to Progression of Fibrosis in EoE

Impact of Delayed EoE Diagnosis on Disease Progression and QoL

Importance of Assessing Key Disease Domains in EoE Infographic

Importance of Assessing Multiple Disease Domains in EoE

Importance of Early Diagnosis of Pediatric EoE

Importance of Monitoring and Maintenance in EoE

In It Together: An Interdisciplinary Approach to EoE Care

Interdisciplinary Care for EoE: Experts Offer Food for Thought

Interplay of Barrier Dysfunction and Type 2 Inflammation in EoE

It Takes a Village: Patient-Centered Care in Pediatric EoE

Managing the Risk of Fibrostenosis in EoE

More Than Eosinophils: A Closer Look at the Pathophysiology of EoE

Multifaceted Burden of Pediatric EoE

Patient Burden in Eosinophilic Esophagitis

Patient Case - The Value of a Complete Pathology Report in EoE

Patient Case - The Value of an Interdisciplinary Team in EoE Patient Care

Scientific Advances in EoE and Impact on Clinical Practice

The Need for Maintenance Therapy in EoE

UEGW 2024 | Something to Chew On: Exploring Biologics in EoE Management

Keeping an Eye on Pediatric EoE